Back to results
US 5,910,573 AGranted
Monomeric and dimeric antibody-fragment fusion proteins
AssigneeMerck Patent GmbH
InventorsAndreas Pluckthun, Peter Pack
Life of this patent
Estimating the term…
Abstract
The present invention describes a new class of antigen binding molecules which contain Fv-fragments of an antibody but do not use the constant antibody domains. They can also dimerize with other antibody fragment molecules or with non-antibody fragment molecules to form bi- or multifunctional antibody-fragment fusion proteins and so-called miniantibodies, respectively. The new fusion proteins can be used in the broad field of diagnostic and therapeutical medicine.
Claims19
A dimeric protein comprising two monomeric fusion proteins in a noncovalent interaction, wherein
- the orientation of the monomeric fusion proteins in the dimer is identical with respect to their N- and C-termini,
- the noncovalent interaction between monomeric fusion proteins is formed between interactive peptides on each monomeric fusion protein, which peptides are identical with each other or nonidentical, and
- each monomeric fusion protein is a monomeric antibody-fragment fusion protein comprising:
- (a) a single chain Fv (scFv) fragment of an antibody,
- (b) a linker peptide, and
- (c) a first interactive peptide comprising a first amphiphilic helical peptide containing up to 50 amino acids, said first amphiphilic helical peptide being capable of forming a dimer with a second amphiphilic helical peptide by noncovalent interaction,
- wherein the C-terminus of (a) is fused with the N-terminus of (b), and the C-terminus of (b) is fused with the N-terminus of (c) and,
- with the proviso that if either monomeric fusion protein comprises a helical peptide which is a jun-zipper, the other monomeric fusion protein may not comprise a helical peptide which is a jun-zipper.
5 more elements
Dependencies are inferred from the claim text.